Daily Edition · Page 1

THE DAILY INDEX

Technology, AI, software, security, crypto and business

Across today’s newsletters

Today’s Index

STABLECOIN WARS HEAT UP AS CIRCLE ASKS CONGRESS TO REIN IN TETHER

Circle and Coinbase are asking Congress to give the Treasury more authority to scrutinize the issuers of Tether, the leading stablecoin issuer, and its banking partner. The executives are accusing Tether of enabling illicit activities and promoting its own USD-backed cryptocurrencies as more compliant alternatives. Tether leads the stablecoin industry by a wide margin, but the competition between Circle and Tether has been intense over the past couple of years.

NEW FDA-APPROVED DRUG MAKES SEVERE FOOD ALLERGIES LESS LIFE-THREATENING

The FDA has approved an antibody drug called omalizumab (brand name Xolair) as an injection to lessen allergic reactions to foods in people ages 1 and up. The drug works by binding to a class of antibodies called immunoglobulin E, preventing them from triggering an allergic response. It doesn't eliminate food allergies, but it will help reduce the health impact if accidental exposure occurs. The drug's effects are not universal - in studies, around 17% of the people receiving the drug showed no significant improvement in their sensitivity to allergy-triggering food.

SOFTBANK FOUNDER REPORTEDLY AIMS TO RAISE $100 BILLION TO BUILD AI CHIP COMPANY THAT WOULD RIVAL NVIDIA — PROJECT IZANAGI MIGHT LEVERAGE ARM DESIGN

Project Izanagi is a new chip venture from Softbank's founder that aims to compete with Nvidia in the artificial intelligence processor space. The project seeks to complement Softbank's Arm Holdings, which designs processor architectures. It is unclear whether the AI processors designed by Project Izanagi will rely on technologies developed by Arm. The project may affect Arm's plans to create reference chip designs for various workloads. It is separate from any collaboration with OpenAI.

TLDR IndexPage 1